Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Tev...

FDA Recall #D-0075-2018 — Class III — October 12, 2017

Recall #D-0075-2018 Date: October 12, 2017 Classification: Class III Status: Terminated

Product Description

Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.

Reason for Recall

Labeling: Incorrect or Missing Package Insert.

Recalling Firm

Genzyme Corporation — Northborough, MA

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

9,343 single dose vials

Distribution

Nationwide

Code Information

Lot #: K5006Y01; Exp. 08/31/18 Lot #: K5006Y03; Exp. 08/31/18 Lot #: K6001Y01; Exp. 03/31/19

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated